These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 8938152

  • 1. Tumoral progression of human breast epithelial cells secreting FGF2 and FGF4.
    Souttou B, Gamby C, Crepin M, Hamelin R.
    Int J Cancer; 1996 Nov 27; 68(5):675-81. PubMed ID: 8938152
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2168-77. PubMed ID: 8481920
    [Abstract] [Full Text] [Related]

  • 6. Fibroblast growth factor 3 is tumorigenic for mouse mammary cells orthotopically implanted in nude mice.
    Hajitou A, Calberg-Bacq CM.
    Int J Cancer; 1995 Nov 27; 63(5):702-9. PubMed ID: 7591288
    [Abstract] [Full Text] [Related]

  • 7. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
    Wellstein A, Lupu R, Zugmaier G, Flamm SL, Cheville AL, Delli Bovi P, Basilico C, Lippman ME, Kern FG.
    Cell Growth Differ; 1990 Feb 27; 1(2):63-71. PubMed ID: 1964794
    [Abstract] [Full Text] [Related]

  • 8. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
    Maerz WJ, Baselga J, Reuter VE, Mellado B, Myers ML, Bosl GJ, Spinella MJ, Dmitrovsky E.
    Oncogene; 1998 Aug 13; 17(6):761-7. PubMed ID: 9715278
    [Abstract] [Full Text] [Related]

  • 9. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
    Brondyk WH, Boeckman FA, Fahl WE.
    Oncogene; 1991 Jul 13; 6(7):1269-76. PubMed ID: 1861869
    [Abstract] [Full Text] [Related]

  • 10. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.
    Talarico D, Basilico C.
    Mol Cell Biol; 1991 Feb 13; 11(2):1138-45. PubMed ID: 1990270
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 13; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P, Bonaccorsi L, Baldi E, Chiasserini C, Forti G, De Chiara G, Lucibello M, Mongiat M, Iozzo RV, Garaci E, Cozzolino F, Torcia MG.
    Prostate; 2002 Dec 01; 53(4):310-21. PubMed ID: 12430142
    [Abstract] [Full Text] [Related]

  • 13. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
    Valverius EM, Ciardiello F, Heldin NE, Blondel B, Merlo G, Smith G, Stampfer MR, Lippman ME, Dickson RB, Salomon DS.
    J Cell Physiol; 1990 Nov 01; 145(2):207-16. PubMed ID: 2174061
    [Abstract] [Full Text] [Related]

  • 14. Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
    Damen JE, Greenberg AH, Wright JA.
    Biochim Biophys Acta; 1991 Sep 23; 1097(2):103-10. PubMed ID: 1911883
    [Abstract] [Full Text] [Related]

  • 15. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
    Braun L, Goyette M, Yaswen P, Thompson NL, Fausto N.
    Cancer Res; 1987 Aug 01; 47(15):4116-24. PubMed ID: 2440558
    [Abstract] [Full Text] [Related]

  • 16. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).
    Bagheri-Yarmand R, Kourbali Y, Mabilat C, Morère JF, Martin A, Lu H, Soria C, Jozefonvicz J, Crépin M.
    Br J Cancer; 1998 Jul 01; 78(1):111-8. PubMed ID: 9662260
    [Abstract] [Full Text] [Related]

  • 17. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
    Giavazzi R, Giuliani R, Coltrini D, Bani MR, Ferri C, Sennino B, Tosatti MP, Stoppacciaro A, Presta M.
    Cancer Res; 2001 Jan 01; 61(1):309-17. PubMed ID: 11196179
    [Abstract] [Full Text] [Related]

  • 18. Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progression.
    Kao S, Mo J, Baird A, Eliceiri BP.
    Oncol Rep; 2012 Jun 01; 27(6):1807-14. PubMed ID: 22407271
    [Abstract] [Full Text] [Related]

  • 19. Inducible expression of FGF-3 in mouse mammary gland.
    Ngan ES, Ma ZQ, Chua SS, DeMayo FJ, Tsai SY.
    Proc Natl Acad Sci U S A; 2002 Aug 20; 99(17):11187-92. PubMed ID: 12169667
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor.
    Talarico D, Ittmann M, Balsari A, Delli-Bovi P, Basch RS, Basilico C.
    Proc Natl Acad Sci U S A; 1990 Jun 20; 87(11):4222-5. PubMed ID: 2190216
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.